Tema ETFs
CTMX icon

Tema ETFs’s CytomX Therapeutics CTMX Stock Holding History

Tema ETFs’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$670K Buy
246,277
+17,290
+8% +$57.7K 0.02% 362
2026
Q2 		$859K Buy
228,987
+1,482
+0.7% +$5.66K 0.03% 319
2026
Q1 		$1.07M Buy
+227,505
New +$1.15M 0.07% 229

Other funds holding CTMX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
Miller Financial Services
Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Congress Park Capital
Congress Park Capital Saratoga Springs, New York $381M AUM 20.14% 1-Year Est. Return
WestHill Financial Advisors
WestHill Financial Advisors San Rafael, California $597M AUM 13.09% 1-Year Est. Return
Investors Research Corp
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Tema ETFs's CTMX Position: Q3 2026 in Review

Tema ETFs increased its CytomX Therapeutics (CTMX) stake by 7.6% in Q3 2026, buying an estimated $57.7K and bringing the position to 246,277 shares worth $670K. The position accounts for 0.02% of the portfolio, ranked #362.

Tema ETFs first reported a position in CTMX in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.07M in Q1 2026. 11 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.

  • Tema ETFs held 246,277 shares of CytomX Therapeutics worth $670K as of Q3 2026.
  • Tema ETFs bought 17,290 CytomX Therapeutics shares in Q3 2026, an estimated $57.7K.
  • CytomX Therapeutics made up 0.02% of Tema ETFs's portfolio in Q3 2026, its #362 holding.
  • Tema ETFs first reported a position in CytomX Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Tema ETFs's CytomX Therapeutics position peaked at $1.07M in Q1 2026.
  • 11 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.